Enodia Therapeutics: SeedDevelops small-molecule therapies for targeted protein degradation at the point of synthesisOct 4, 2026RoundOSEnodia TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeed · AIBiotechFranceEuropeSeed